Single-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas by Harpaz, Nofar, Mittelman, Tamir, Beresh, Olga, Griess, Ofir, Furth, Noa, Salame, Tomer-Meir, Oren, Roni, Fellus-Alyagor, Liat, Harmelin, Alon, Alexandrescu, Sanda, Marques, Joana Graca, Filbin, Mariella G., Ron, Guy, Shema, Efrat

Get full text

Treatment Modalities and Outcomes of Multiple Myeloma Patients with Spinal Cord Compression: A Single Center Experience by Shragai, Tamir, Illouz, Yael, Melamed, Natan, Trestman, Svetlana, Mittelman, Moshe, Zetserov, Inna, Avivi, Irit Mazza, Cohen, Yael C.

Get full text

Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma by Avivi, Irit, Balaban, Roi, Shragai, Tamir, Sheffer, Gabi, Morales, Miguel, Aharon, Anat, Lowenton‐Spier, Noa, Trestman, Svetlana, Perry, Chava, Benyamini, Noam, Mittelman, Moshe, Tabib, Yaara, Bar Lev, Tali, Zavaro, Mor, Herishanu, Yair, Luttwak, Efrat, Cohen, Yael C.

Request full text

A Phase II Multicenter Clinical Trial Assessing the Safety and Efficacy of Ixazomib, Pomalidomide and Dexamethasone Combination As Second or Third-Line Treatment for Triple-Class E... by Cohen, Yael C., Shragai, Tamir, Lavi, Noa, Vaxman, Iuliana, Chubar, Evgeni, Gatt, Moshe E, Ganzel, Chezi, Magen, Hila, Luttwak, Efrat, Mittelman, Moshe, Tzoran, Inna, Vainstein, Vladimir, Lowenton-Spier, Noa, Melamed, Natan, Krayzler, Ella, Pereg, Ilana, Avivi Mazza, Irit

Get full text

Outcomes of Acute Myeloid Leukemia Patients Suffering from an Additional Active Malignancy Treated with Venetoclax and Azacitidine: A Single Center Experience by Moshe, Yakir, Levi, Shai, Neaman, Miriam, Gat, Roi, Levi, Mor, Eilati, Nili, Fridberg, Gil, Bornstein, Yotam, Shragai, Tamir, Neuman, Tsipora, Vitkon, Roy, Shachar, Eliya, Sarid, David, Merimsky, Ofer, Mittelman, Moshe, Avivi Mazza, Irit

Get full text

Highly Ordered Large-Scale Neuronal Networks of Individual Cells – Toward Single Cell to 3D Nanowire Intracellular Interfaces by Kwiat, Moria, Elnathan, Roey, Pevzner, Alexander, Peretz, Asher, Barak, Boaz, Peretz, Hagit, Ducobni, Tamir, Stein, Daniel, Mittelman, Leonid, Ashery, Uri, Patolsky, Fernando

Get full text

P560: IMPROVEMENT IN OVERALL AND RELAPSE FREE SURVIVAL OF AML PATIENTS OVER THE AGE OF 75 SINCE THE APPROVAL OF VENETOCLAX IN A REAL‐WORLD SINGLE CENTER STUDY by Moshe, Yakir, Levi, Shai, Neeman, Miri, Gat, Roi, Levi, Mor, Eilati, Nili, Shragai, Tamir, Basood, May, Segman, Yafit, Baron, Yaeli, Luttwak, Efrat, Neuman, Tsipora, Vitkon, Roy, Mittelman, Moshe, Avivi, Irit

Get full text

P571: OUTPATIENT INITIATION OF VENETOCLAX‐AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS by Gat, Roi, Neeman, Miri, Levi, Shai, Levi, Mor, Eilati, Nili, Bronstein, Yotam, Shragai, Tamir, Neuman, Tsipora, Segman, Yafit, Vitkon, Roy, Mittelman, Moshe, Avivi, Irit, Moshe, Yakir

Get full text

Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery by Ashkenazi, U, Fridlander, M, Mittelman, M, Zeidman, A, Fradin, Z, Hendel, D, Tamir, L, Cohen, A. M

Get full text